Clinical Trial Update: A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

This completed Phase 1 trial compared a clindamycin and benzoyl peroxide combination gel (1.2%/3.75%) to Onexton Gel for treating acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% (clindamycin phosphate and benzoyl peroxide gel)
• Onexton Gel (clindamycin phosphate and benzoyl peroxide gel)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED